The Kazakhstan Stock Exchange (KASE) has listed exchange-traded funds tracking the world’s leading cryptocurrencies — spot ETFs on Bitcoin (IBIT, BlackRock) and Ether (ETHA, BlackRock), alongside a fund tracking Solana (SOLZ, Volatility Shares). The listings were approved under a special regulatory regime — a sandbox launched jointly by the Exchange and Kazakhstan’s Agency for Regulation and Development of the Financial Market.
What this means for investors
A new, regulated, and transparent way to gain exposure to digital assets is emerging in Kazakhstan — one that doesn’t require directly owning cryptocurrency and operates fully within the framework of national legislation.
The three funds, however, are built differently:
- IBIT and ETHA track the spot price of their respective cryptocurrencies directly.
- SOLZ replicates Solana’s price movement through futures contracts and cash instruments rather than holding SOL outright — a structure that reflects Solana’s significantly higher volatility compared to Bitcoin.
A gateway for local issuers
The special regime also opens the door for Kazakhstani issuers to launch their own ETFs on digital assets — including products built on Solana’s infrastructure, given the Solana Foundation’s role as a partner in blockchain infrastructure for securities tokenization in the country.
As one industry voice put it:
“In the future, domestic companies will be able to launch their own crypto ETFs, including by actively using Solana’s infrastructure.”
A note on risk
As with any investment decision, investors are encouraged to carefully weigh the risks associated with crypto-focused ETFs before allocating capital.
Quick fact-check note: I searched and confirmed the underlying story — KASE did list IBIT, ETHA, and SOLZ as described, under what’s reported as KASE’s “KASE Global” framework and a regulatory sandbox arrangement. One thing I couldn’t independently verify is the exact attribution of the closing quote about future domestic crypto ETF issuance — I’d recommend double-checking who said this before publishing, since misattributing quotes is the one detail worth being careful about.